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formation of novel Ig or TCR variable-domain exons. Null
mutations in the genes encoding either RAG1 or RAG2
result in an early arrest in lymphocyte development, char-
acterized by the complete absence of V(D)J recombina-
tion. Artificial expression of RAG1 and RAG2 is sufficient
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recombinase.The Johns Hopkins University School of Medicine
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oping B cells, the first wave of RAG expression occurs
in pro-B cells in which the Ig heavy chain locus is being
rearranged (Li et al., 1993). Productive heavy chain geneSummary
rearrangement and pre-B cell receptor (pre-BCR) ex-
pression lead to early pre-B cell proliferation and down-Although expression of the RAG1 and RAG2 genes is
regulation of RAG expression, a process that may serveessential for lymphocyte development, the mecha-
to prevent allelic heavy chain gene rearrangement (Gra-nisms responsible for the lymphoid- and develop-
wunder et al., 1995). RAG expression increases againmental stage-specific regulation of these genes are
during the small, resting late pre-B cell stage coincidentpoorly understood. We have identified a novel, evolu-
with the second period of V(D)J recombination duringtionarily conserved transcriptional enhancer in the
which Ig light chain gene rearrangement takes placeRAG locus, called Erag, which was essential for the
(Grawunder et al., 1995). Successful light chain re-expression of a chromosomal reporter gene driven by
arrangement and subsequent expression of surface IgMeither RAG promoter. Targeted deletion of Erag in the
result in developmental progression to the immature Bmouse germline results in a partial block in B cell
cell stage. Surface Ig expression does not necessarilydevelopment associated with deficient V(D)J recombi-
result in the cessation of light chain gene rearrangement,nation, whereas T cell development appears unaf-
however, and RAG transcripts continue to be expressedfected. We found that E2A transcription factors bind
in a fraction of normal sIgMsIgD immature B cellsto Erag in vivo and can transactivate Erag-dependent
(Grawunder et al., 1995; Li et al., 1993; Rolink et al.,reporter constructs in cotransfected cell lines. These
1993). Immature B cells displaying self-specificity con-findings lead us to conclude that RAG transcription is
tinue to transcribe the RAG1 and RAG2 genes and goregulated by distinct elements in developing B and
on to alter their BCR by further light chain gene re-T cells and that Erag is required for optimal levels of
arrangement, a process referred to as receptor editingRAG expression in early B cell precursors but not in
(Pelanda et al., 1997; Radic and Zouali, 1996).T cells.
The pattern of RAG expression in developing T cells is
very similar to that in developing B cells. RAG transcriptIntroduction
levels are high during the early CD4CD8 stages of
T cell development and diminish after successful V-to-
The variable region exons of immunoglobulin (Ig) and DJ rearrangement results in the expression of a pre-
T cell receptor (TCR) genes are assembled from their TCR and several rounds of rapid proliferation. RAG ex-
component V, D, and J gene segments during early B pression is upregulated again after cell cycle exit, and
and T cell development by a series of site-specific DNA TCR locus rearrangement begins (Wilson et al., 1994).
recombination reactions known as V(D)J recombination Successful TCR gene rearrangement and surface ex-
(Tonegawa, 1983). Proteins encoded by recombination pression of a complete / TCR are insufficient to turn
activating genes 1 and 2 (RAG1 and RAG2) are essential off RAG gene expression. RAG expression and V(D)J
for this process. Expressed at significant levels only in recombination continue until TCR engagement during
B and T cell progenitors, the RAG proteins are responsi- positive selection (Brandle et al., 1992). Positively se-
ble for the recognition and double-stranded (ds) cleav- lected DP thymocytes terminate RAG expression, ma-
age of conserved DNA elements known as recombina- ture to CD4CD8 or CD4CD8 single-positive (SP)
tion signal sequences (RSSs) that flank all rearranging thymocytes, and eventually exit the thymus. Unlike the
gene segments (reviewed in Fugmann et al., 2000). Pairs case in B cells, ongoing TCR locus receptor editing
of dsDNA breaks derived from rearranging gene seg- does not seem to be a prominent mechanism contribut-
ments are then repaired by the nonhomologous end ing to self-tolerance.
joining machinery expressed in all cells, resulting in the Since regulated expression of RAG1 and RAG2 plays
a critical role in the lymphoid and stage specificity of
V(D)J recombination, several groups have engaged in*Correspondence: mss@uclink4.berkeley.edu
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experiments aimed at identifying the DNA elements and G418. Two weeks after transfection, the levels of GFP
expression were determined by flow cytometry. In con-transcription factors that regulate RAG gene expression.
The RAG1 and RAG2 genes are physically linked in the trast to our previous results using transient transfection
assays in which both the RAG1 (nt 243 to 72) andgenome and are convergently transcribed. Previous
work from our laboratory and others has shown that RAG2 (nt 279 to 123) promoters were active in sev-
eral pro-B cell lines (Lauring and Schlissel, 1999), “pro-both RAG1 and RAG2 promoters are highly conserved
between mouse and human (Brown et al., 1997; Fuller moter-only” stable transfectants exhibited levels of GFP
expression virtually identical to those of untransfectedand Storb, 1997; Kurioka et al., 1996; Lauring and Schlis-
sel, 1999; Zarrin et al., 1997). Unlike the murine and cells (Figure 1C, upper panels). Inclusion of the immuno-
globulin heavy chain intronic enhancer (E) in the re-human RAG1 promoters that display activity in lymphoid
and nonlymphoid cell lines, the murine RAG2 promoter porter construct resulted in 10% to 20% GFP cells.
Control experiments revealed that transfection efficiencydisplays lymphoid-specific activity and is regulated dif-
ferently in B and T cell lines (Lauring and Schlissel, was comparable among the various reporter constructs
(data not shown). Therefore, the most likely explanation1999; Wang et al., 2000). Given the complexity of their
expression patterns, we and others have speculated for the lack of GFP expression in the promoter-only
constructs is that RAG promoters are unable to over-that regulated RAG expression requires sequences in
addition to promoters such as enhancers, locus control come the repressive effects of neighboring chromatin
structure when integrated into chromosomal DNA.regions (LCRs), or insulators.
To identify potential regulatory elements in the RAG Interestingly, Erag, which showed very modest RAG2
promoter stimulation in the transient transfection assay,locus, we devised a novel reporter construct in which
GFP expression is driven by either RAG1 or RAG2 pro- had a much greater effect on chromosomal reporter
construct activity (30%–40% GFP cells) than did themoter in conjunction with potential enhancer sequences
from the RAG locus in stably transfected cell lines. Using E control (Figure 1C, compare upper and middle pan-
els). This effect was apparent in reporter constructsthis assay system, we identified a highly conserved RAG
locus enhancer. Targeted deletion of this element in based on the RAG1 promoter as well (Figure 1C, lower
panels). No difference in mean fluorescence intensity ofmice had a profound effect on B cell, but not T cell,
development. GFP cells within transfected populations was observed
in Eor Erag-containing constructs. Erag displayed sim-
ilar RAG enhancer activity in three other RAG-express-Results
ing pro-and pre-B cell lines (data not shown). An adja-
cent 2.3 kb XbaI fragment (Fragment D in Figure1A) asIdentification of a New Cis-Acting Element
well as a large number of other RAG-locus DNA frag-within the RAG Locus
ments (Figure 1C, middle panels and data not shown)In an attempt to identify cis-acting elements that contrib-
failed to rescue RAG promoter activity in stably trans-ute to high-level, tissue-, and stage-specific expression
fected cells, verifying the specificity of the Erag effectof RAG genes, we initially tested restriction fragments
on the RAG1 and RAG2 promoters. We also found thatgenerated from an 120 kb P1 bacteriophage clone of
Erag shares with other classic enhancers the ability tothe murine RAG locus for the ability to enhance RAG-2
function in either orientation (Figure 1C, middle panels).promoter activity in a transient transfection luciferase
To determine whether Erag-dependent chromosomalassay. These studies led to the identification of a 2.3 kb
reporter construct activity was variegated within individ-XbaI fragment (Fragment C in Figure 1A; referred to
ual transfectant clones, we generated 49 single-cellhereafter as Erag) located 22 kb 5 of the RAG2 first
clones from the pool of 220-8 cells stably transfectedexon that consistently gave 2-fold stimulation of pro-
with the Erag-RAG2 reporter shown in Figure 1C. Eachmoter activity upon transfection into the Abelson virus
clone demonstrated uniform GFP expression levelstransformed pro-B cell line, 220-8 (data not shown).
ranging from none (36%) to10-fold above backgroundWhile this enhancement effect was reproducible, its
(10%; see Supplemental Figure S1 at http://www.immunity.magnitude led us to doubt the biological relevance of
com/cgi/content/full/19/1/105/DC1). Thus, we concludeErag. To determine whether Erag activity might be more
that Erag allows the RAG1 or RAG2 promoter to over-striking within the context of chromatin structure, we
come the repressive effects of chromatin structure atdesigned a stable transfection assay of enhancer activ-
only a subset of integration sites.ity. As depicted in Figure 1B, the chromosomal reporter
construct consists of an enhancer test site 5 of either
the murine RAG1 or RAG2 promoter that drives expres- Erag Activates Transcription Specifically
in RAG-Expressing B Cell Linession of a green fluorescent protein (GFP) cDNA. In addi-
tion, the construct contains a neomycin resistance cas- The results described above demonstrate that Erag is
capable of activating RAG1 and RAG2 promoter activitysette for selection of stable transfectants separated
from the reporter cassette by two copies of chicken in the 220-8 pro-B cell line. We went on to test the ability
of Erag to regulate the RAG promoters in other B cell,-globin insulator (Chung et al., 1993). The insulator
should prevent the drug selection cassette itself from T cell, and nonlymphoid cell lines. Although Erag was
active in RAG-expressing early B cell lines (Figure 1Cinfluencing reporter construct activity.
The chromosomal reporter construct with or without and data not shown), it was inactive in mature B cell
lines (CH33 and M12) that do not express the endoge-Erag was linearized and then introduced into the 220-8
pro-B cell line by electroporation. Bulk (uncloned) popu- nous RAG genes (Figure 1D). Failure of Erag to activate
transcription in mature B cells was not due to unrespon-lations of transfectants were selected and expanded in
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Figure 1. Identification of a RAG Locus Enhancer Using a Stable Transfection Assay
(A) Partial map of the murine RAG locus. The position of a 2.3 kb subfragment (labeled “C” and subsequently referred to in the text as Erag)
of a 9 kb SpeI fragment beginning 16 kb 5 of the RAG2 promoter is shown.
(B) Diagram of reporter construct for stable transfection assay. Ins indicates the 1.2 kb chicken -globin insulator sequence.
(C) FACS histograms of GFP expression in transfected cell lines. The AMuLV-transformed murine pro-B cell line 220-8 was stably transfected
with linearized reporter constructs in which a RAG promoter was paired with either E, Erag (Fragment C), or Fragment D as indicated. After
2 weeks of selection in G418, pools of surviving cells were analyzed by flow cytometry for GFP expression. The fluorescence histogram of
untransfected cells (thin solid line) was overlaid with those of various transfectant pools containing a RAG promoter alone (bold solid line) or
in conjunction with either E (positive control), Erag, or Fragment D (dashed or dotted lines). Note that histograms of transfected pools from
RAG promoter-only constructs and the promoter-plus-Fragment D construct are indistinguishable from that of untransfected cells.
(D and E) Experiments were conducted as described in (C). Recipient cell lines included (D) mature B cell lymphomas CH33 and M12 and (E)
T cell lines Jurkat, VL3-3M2, and 2017. Constructs containing E or E served as positive controls in the B cell lines and T cell lines,
respectively.
siveness of the RAG2 promoter in these cells since a ure 1D and data not shown). Furthermore, inclusion of
Erag had no effect on RAG promoter activity when thesignificant percentage of GFPcells were observed in
both E and SV40 enhancer-containing constructs (Fig- chromosomal reporter construct was introduced into
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various RAG-positive or negative T cell lines (Figure 1E), Deletion of Erag Partially Blocks B Cell Differentiation
at the Pro-B Stagewhereas the TCR  enhancer (E) control construct en-
hanced RAG promoter activity in each T cell line. Taken We first examined the effect of Erag deletion on lympho-
cyte development by multiparameter flow cytometry.together, these experiments lead us to conclude that
Erag is required for mediating developmental stage-spe- Interestingly, analysis of early B cell populations defined
by B220, CD43, and IgM expression showed that thecific RAG promoter activity in B cell but not T cell lines.
fraction of pro-B cells (IgM B220CD43) was in-
creased (from 17.2% to 24.5% of sIgM cells), whereas
the percentage of pre-B cells (IgM B220CD43) wasStriking Conservation of Erag among Multiple
Mammalian Species reduced (from 37.5% to 15.6% of sIgM cells) in Erag/
mice compared to wild-type controls (Figure 3A, upperTo further test the potential significance of Erag, we
identified and cloned the fragment from a human RAG panels). As a result, the pro-B:pre-B ratio in Erag/
mice is significantly higher than that found in wild-typelocus BAC that crosshybridized to the murine Erag DNA
fragment. Stable transfection of this 1.7 kb human RAG mice. Furthermore, we observed a marked reduction of
IgM cells in Erag/bone marrow (from29% to15%locus fragment, cloned in the chromosomal reporter
construct, into the 220-8 pro-B cell line revealed an in- of total mononucleated bone marrow cells; Figure 3A,
lower panels).crease in the number of GFP cells similar to that found
with murine Erag, thereby providing functional confirma- We found that the absolute numbers of bone marrow
cells and splenocytes were decreased in Erag/ mice,tion that this homologous region contains the human
version of Erag (see Supplemental Figure S2 at http:// while the number of total thymocytes appeared unaf-
fected (data not shown). Enumeration of different sub-www.immunity.com/cgi/content/full/19/1/105/DC1).
DNA sequence analysis revealed a 1.1 kb human DNA sets of bone marrow B cells revealed that Erag/ mice
had equivalent numbers of pro-B cells but about 2.5-sequence located in an identical position relative to the
RAG2 promoter with greater than 90% sequence identity fold fewer B220 cells, 3-fold fewer pre-B cells, and
3-fold fewer IgM B cells than wild-type mice (Figurebetween the human and murine Erag fragments (Figure 2
and data not shown). Using a degenerate PCR ap- 3C). Similarly, the percentage of B220 B lymphocytes
was also decreased in the spleen compared to wild-proach, we amplified, cloned, and sequenced homolo-
gous DNA from the cow, sheep, and pig genomes. As type mice. However, in contrast to the marked effect on
B cell development, thymocyte development in Erag/shown in Figure 2, approximately 600–700 bp of Erag
was highly homologous (80%) among these five mam- mice appeared normal, as evidenced by patterns of
CD4, CD8, CD44, and CD25 expression that were indis-malian species. Of particular interest is the sequence
of the human-mouse homology region showing several tinguishable from wild-type and by equivalent absolute
cell numbers (Figure 3B and data not shown). Takenconserved consensus sites for known transcription fac-
tors, including E box proteins, Ikaros, LEF/TCF, GATA together, these results show that normal B cell but not
T cell development depends upon Erag activity.factors, and Pax-5/BSAP.
Decreased RAG Transcript Levels in Developing
Generation of Erag-Deficient Mice B Cells in Erag/ Mice
To determine the role of Erag in the developmental regu- To verify that the partial block at the pro-B and pre-B
lation of endogenous RAG locus expression, we used cell stages of development in Erag/ mice was due to
homologous recombination in ES cells to generate mice reduced RAG transcript levels, we designed quantitative
with a deletion of this element. As shown in Supplemen- real-time RT-PCR assays for RAG1 and RAG2 tran-
tal Figure S3A at http://www.immunity.com/cgi/content/ scripts. We express the results of these analyses as the
full/19/1/105/DC1, our targeting construct was gener- ratio of RAG transcript to control HPRT transcript levels.
ated by replacement of a 1.7 kb ScaI-SmaI fragment Using these assays, we observed that the expression
containing the conserved region of Erag with a neomycin pattern of RAG transcripts measured by real-time RT-
resistant gene (neor) flanked by loxP sites. Of 50 G418 PCR was consistent with previous studies (Grawunder
resistant ES cell clones screened for homologous re- et al., 1995). RAG1 and RAG2 transcripts were high in
combination, five clones were correctly targeted as con- both pro-B and pre-B cell fractions, somewhat lower
firmed by Southern blot analyses (data not shown). Two in immature B cells, and negligible in mature B cells
independent recombinant clones were injected into (Figure 4A).
C57BL/6 blastocysts and the resulting chimeric mice As shown in Figures 4B and 4C, RAG expression was
were bred to obtain germline transmission of the tar- significantly diminished in Erag/ B cell progenitors as
geted allele (designated N). To eliminate the neomycin compared with wild-type littermates in each of three
selection cassette, mice heterozygous for the targeted independent sorting experiments. Specifically, deletion
allele were bred to EIIa-Cre transgenic mice that express of Erag resulted in substantial decreases in RAG1 tran-
Cre recombinase in early embryonic stages. Deletion of script levels (5- to 15-fold), whereas the effect on RAG2
the Neor gene was confirmed by Southern blot analysis transcript levels was less profound (2- to 3-fold). In
using two flanking probes outside of the targeted region agreement with results from the stable transfection
and a Neo probe (see Supplemental Figure S3B at http:// studies presented above, these data indicate that Erag
www.immunity.com/cgi/content/full/19/1/105/DC1). The is critical for normal RAG transcription during B cell
heterozygous Erag/ mice were subsequently crossed development.
to generate Erag/, Erag/, and Erag/ littermates for Despite the absence of an apparent defect in T cell
development, we went on to examine RAG transcriptfurther analysis.
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Figure 2. Erag Is Highly Conserved among a Set of Five Mammalian Species
ClustalW alignment of Erag region sequences from the indicated species. The human sequence was obtained from a 1.7 kb restriction fragment
of a human RAG locus BAC identified by hybridization to the murine sequence. Pig, sheep, and cow sequences were obtained from PCR
reactions using primers designed based on the human-mouse sequence conservation (positions indicated by arrows). Consensus transcription
factor binding sites are indicated in thick solid lines above the DNA sequence.
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Figure 3. Impaired B Cell Development and
Normal T Cell Development in Homozygous
Erag Mutant Mice
Bone marrow cells, thymocytes, and spleno-
cytes obtained from 6- to 7-week-old wild-
type and homozygous mutant mice were ana-
lyzed by flow cytometry. The figure shown is
representative of staining from at least six
separate mice of each genotype. The per-
centage of cells in each gate is presented as
the mean  SD (n  6) and is indicated in
each gate. All data were gated by forward
and side light-scattering prior to analysis. (A)
Bone marrow cells from wild-type (left panels)
and Erag/ (right panels) mice were stained
with FITC-anti-IgM, PE-anti-B220, and biotin-
anti-CD43 revealed by SA-QR. Upper, IgM-
gated bone marrow cells; lower, ungated
bone marrow cells. Pro-B cells are IgMB220
CD43 while pre-B cells are IgMB220CD43.
(B) Thymocytes (left panel, wild-type; right
panel, Erag/) were stained with FITC-anti-
CD8 and PE-anti-CD4 antibodies. (C) Abso-
lute cell numbers were calculated based on
the relative percentages determined by FACS
analysis in (A) and (B), and total numbers of
RBC-free bone marrow cells isolated from
both femurs and tibiae of individual mice.
Splenic cells from mice of the indicated geno-
types were stained with antibody specific for
B220, and absolute cell numbers were calcu-
lated as above six mice of each genotype
were analyzed with the error bars indicating
standard deviation of the data.
levels in total thymocytes and in sorted double-negative binase activity, we examined recombination reaction in-
termediates (dsDNA breaks at recombination signal(DN) or double-positive (DP) thymocytes. Real-time RT-
PCR analysis revealed similar RAG1 and RAG2 tran- sequences termed signal broken signal ends or SBE).
The levels of these SBEs provide a direct measure ofscript levels in thymocytes from wild-type mice and
Erag/ mice (Figure 4D). We conclude that deletion of recombinase activity within a population of cells (Con-
stantinescu and Schlissel, 1997; Schlissel et al., 1993).Erag has a significant effect on RAG expression in B
cell precursors but little or no observable effect on RAG As assessed by LM-PCR, we found that dsDNA breaks
at the 5 of DFL16.1 RSS, which is associated with VH-expression in T cell precursors.
to-DJH rearrangement, are diminished at least 5-to-10-
fold in Erag/ as compared to wild-type pro-B cell DNAV(D)J Recombinase Activity Is Diminished
in Erag/ Mice (Figure 5A, 5DH SBE). This decrease in V-to-DJ re-
arrangement affected VH segments all across the locusTo determine the extent to which reduced RAG tran-
scripts levels in developing B cells affected V(D)J recom- in a similar fashion (data not shown). To assess the
Conserved RAG Locus Enhancer
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Figure 4. Both RAG1 and RAG2 Transcript Levels Are Reduced in Developing B Cells from Erag/ Mice
Real-time “Taqman” RT-PCR was used to determine the amounts of RAG and HPRT mRNA in FACS-purified pro-B cells (IgM B220CD43),
pre-B cells (IgM B220CD43), immature B cells (IgMB220loIgD/lo), and mature B cells (IgMB220hiIgDhi).
(A) Relative RAG1 or RAG2 mRNA expression in sorted populations of wild-type bone marrow B cells. RAG1 (open bar) and RAG2 (solid bar)
transcripts were normalized to HPRT transcript levels in each sample. Results are in arbitrary units relative to HPRT mRNA.
(B) RAG1 transcript levels in RNA purified from sorted pro-B and pre-B cells from wild-type mice as compared to three individual Erag/
mice are shown. Each assay has been normalized based on HPRT expression and is plotted as a percentage of the wild-type value. Error
bars are based on triplicate real-time PCR analyses.
(C) RAG2 transcript levels in wild-type and mutant pro-B and pre-B cells analyzed as in (B).
(D) Relative transcript levels of RAG1 and RAG2 in sorted DN and DP thymocytes. Results represent the mean percentage relative to the
wild-type control  standard deviations for three separate sets of sorts.
extent of DH-to-JH rearrangement in pro-B cells, we uti- LM-PCR assay, however, and its significance remains
uncertain. Thus, decreased levels of RAG1 and RAG2lized a pair of primers that amplify a region of germline
DNA 5 of and including JH1 that is invariably lost upon transcripts in Erag/ mice appear to contribute to a
drop in overall levels of RAG-mediated DNA cleavage,DH-to-JH rearrangement (Hardy et al., 1991). Amplifica-
tion of genomic DNA from Erag/ pro-B cells showed resulting in deficient antigen receptor gene rearrange-
ment during B cell but not T cell development.a significant increase (9-fold) in retention of the se-
quence 5 of JH1, indicating that DH-to-JH rearrangement
is less efficient in Erag/ than in wild-type pro-B cells Induction of RAG Expression In Response to BCR
Crosslinking Is Normal in Erag/ Mice(Figure 5A, top panel).
In addition, we found that dsDNA breaks at the J	1 Given the apparently exclusive effect of Erag deletion
on RAG activity in the B cell lineage, we hypothesizedRSS were decreased at least 10-fold in pre-B cells puri-
fied from Erag/ as compared to wild-type mice (Figure it may be involved in an aspect of RAG regulation
thought to occur in B but not T cells—receptor editing.5B). Interestingly, while no obvious differences were de-
tected between mutant and wild-type thymocytes by Previous studies from Nemazee and coworkers have
defined two populations of immature B cells based oneither flow cytometry or RT-PCR, we observed a subtle
decrease (
2-fold) in the levels of DSBs at RSSs 5 their differential responses to autoantigen stimulation
(Melamed et al., 1998). In the presence of autoantigenof D1 and various J2 RSSs in total thymocytes from
Erag/ mice compared to wild-type mice (Figure 5C). or anti-BCR antibody, IgMlo/IgD cells expressed signifi-
cantly increased levels of RAG2 mRNA, whereas IgMhi/This difference is within the range of variability in the
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frequency of receptor editing would be diminished in
Erag/ mice because of diminished levels of recombi-
nase present in mutant B lineage cells.
Regulation of RAG1 and RAG2 Gene Expression by
Anti-CD3 Crosslinking Is Not Altered in Erag/ Mice
Crosslinking of the TCR-CD3 complex during ex vivo
culture of developing thymocytes was previously shown
to cause downregulation of RAG expression (Turka et
al., 1991). This is thought to mimic the positive selection
signal that stops V(D)J recombination in vivo. To test
whether Erag might play a role in regulating RAG expres-
sion in response to TCR signaling, we performed a time-
course analysis of RAG mRNA levels in thymocytes fol-
lowing anti-CD3 crosslinking or stimulation with phorbol
myristate acetate (PMA) plus ionomycin. RAG1 and
RAG2 transcript levels decreased significantly within
2 hr following anti-CD3 crosslinking and in less than an
hour following stimulation by PMA plus ionomycin in
thymocytes from both wild-type and Erag/ mice (Fig-
ure 6B and data not shown). In contrast, treatment of
thymocyte cultures with a monoclonal antibody to anti-
CD4 or culture in medium without antibodies failed to
result in a significant decrease in RAG expression. Thus,
we conclude that Erag does not play a role in the inac-
tivation of RAG gene expression during T cell develop-
ment.
E2A Binds to Erag in Pro-B Cell Lines and Activates
an Erag-Dependent Reporter Construct
in Nonlymphoid Cells
Computational analysis of the Erag sequence revealed
Figure 5. Reduced Levels of V(D)J Recombination in Pro- and Pre-B six potential E2A binding sites conserved among all five
Cells from Erag/ Mice species analyzed (Figure 2 and data not shown). To
Genomic DNA samples purified from sorted populations of B and test whether any of these sites bound E2A in vivo, we
T cells from wild-type and Erag/ mice were subjected to LM-PCR performed chromatin immunoprecipitation (ChIP) on
to detect broken signal-end recombination reaction intermediates material purified from a novel Abelson virus transformed
(SBE) associated with the DH (A, middle panel), J	1 (B), J2.1 (C, top pro-B cell line that expresses a functional FLAG6xhis-panel), and D1 (C, middle panel) gene segments. LM-PCR products
epitope-tagged version of E2A and from thymocyteswere separated on agarose gels, blotted, and hybridized with radio-
expressing that same tagged protein (Greenbaum andlabeled locus-specific oligonucleotide probes. Serial 3 (A and C)-
and 4 (B)-fold dilutions of genomic DNA samples were analyzed in Zhuang, 2002). As shown in Figure 7A, anti-FLAG immu-
parallel. Direct amplification of a germline DNA sequence 5 of and noprecipitation of chromatin from the tagged (FH) but
including JH1 was used to quantify the extent of DH to JH re- not the control cell line enriched for Erag as well as
arrangement (A, top panel, 5 JH GL). Direct PCR amplification of a for sequences from an independently identified distinctnonrearranging genomic locus, CD14, was used as a control for
RAG locus enhancer (Wei et al., 2002) and the mb-1DNA abundance in each linker-ligated sample.
promoter, but not the RAG1 promoter. ChIP on thymo-
cytes expressing the epitope-tagged E2A revealed that
despite the fact that Erag deletion does not effect RAGIgD cells underwent apoptosis and their RAG2 mRNA
levels became undetectable. We therefore compared expression in the thymus, E2A is nonetheless bound to
this enhancer in T cell progenitors.the effects of BCR ligation on the levels of RAG tran-
scripts in IgMlo/IgD and IgMhi/IgD cells sorted from To test whether E2A could activate transcription from
these binding sites, we generated a set of luciferasewild-type and Erag/ BM cultures (Melamed and Nem-
azee, 1997). While lower relative levels of RAG tran- reporter constructs containing either the RAG1 or RAG2
promoter with or without wild-type or mutant Erag. Thescripts were detected in IgMlo/IgD B cells of Erag/
mice in the presence or absence of BCR ligation, RAG mutant version of Erag, termed Eragm6, contained point
mutations disrupting each of its six potential E2A bind-transcripts increased to a similar extent in response to
BCR engagement in both mutant and wild-type cells ing sites. These reporters were transiently cotransfected
into the 293T human embryonic kidney cell line in the(10- to 30-fold; Figure 6A). Furthermore, the Erag muta-
tion did not alter the striking inactivation of RAG expres- presence of an empty expression vector or expression
vectors encoding either E2A or GATA-3. We found thatsion observed in IgMhi/IgD cells (Figure 6A). Together,
these results suggest that Erag is not required for the cotransfection of E2A but not GATA-3 resulted in an
Erag-dependent stimulation of luciferase activity withBCR-dependent increases in RAG expression associ-
ated with receptor editing. However, we predict that the wild-type Erag but not with Eragm6 (Figure 7C and data
Conserved RAG Locus Enhancer
113
Figure 6. Erag Is Not Required for the BCR-
Dependent Increases in RAG Expression As-
sociated with Receptor Editing or for the In-
activation of RAG Expression upon TCR
Crosslinking
(A) Sorted IgMlow/IgD and IgM high/IgD cells
from Erag/ and wild-type bone marrow cul-
tures were returned to culture for 48 hr with
or without 10 g/ml F(ab)2 anti-IgM before
RNA preparation. RAG1 (left) and RAG2 (right)
transcript levels were measured by real-time
RT-PCR. The data are expressed as the ratio
of RAG transcript to CD19 transcript. Note
that amounts of RAG2 mRNA from IgM high/
IgD cells were not determined because
RAG2 transcript levels were below the limits
of detection. The numbers indicate actual
data values. One of three comparable experi-
ments is shown.
(B) Thymocytes from wild-type (squares) or
Erag/ (circles) mice were incubated with
medium alone or stimulated with plate-bound
anti-CD3 or anti-CD4 antibodies. Cells were
harvested and RNA purified at the indicated
time points. Real-time RT-PCR was per-
formed to quantify RAG1 (open symbols),
RAG2 (filled symbols), and HPRT transcripts.
Data shown are the average of duplicates and
are representative of two independent exper-
iments.
not shown). These experiments suggest that E2A may Work from our lab and others identified the RAG1 and
RAG2 promoters by virtue of their activity in transientbe involved in the function of Erag in developing B cells.
transfection assays. Interestingly, in the present study
we found that both RAG promoters are inactive whenDiscussion
chromosomally integrated. Our finding that Erag was
able to increase the frequency of GFP-expressing cellsA Stable Transfection Assay for Enhancer Activity
In the present study, we have shown that Erag, which from undetectable to 30%–40% (Figure 1C) suggested
that Erag may function to prevent the formation of stablelies 22 kb 5 of the RAG2 promoter in both the mouse
and human genomes, is capable of enhancing expres- repressive structures that silence the RAG promoters.
Furthermore, analysis of single cell transfectant clonession of a reporter gene from either the RAG1 or RAG2
promoter in RAG-expressing pro- and pre-B cell lines revealed that RAG promoter activity was either “all-or-
none” in the presence of Erag (see Supplemental Figurebut not in T cell lines. A stable transfection reporter
construct was key to the discovery of Erag and may be S1 at http://www.immunity.com/cgi/content/full/19/1/
105/DC1). We interpret this observation to indicate thatof value in other searches for enhancer activity. Like
some enhancers and LCRs, Erag’s enhancer activity Erag can overcome the chromatin-dependent inactiva-
tion of the RAG promoters, but only at a subset of chro-was demonstrable only when the reporter construct was
chromosomally integrated. Given the fact that most pre- mosomal locations.
vious systematic attempts to identify transcriptional en-
hancers utilized transient transfection assays, it is possi- Additional RAG Transcriptional Control Elements?
Several other groups have engaged in attempts to iden-ble that elements similar in function to Erag may have
been missed in these types of studies. tify RAG locus regulatory elements. Nussenzweig and
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RAG2 promoter. A second group independently found
a DNase I hypersensitive site 8 kb 5 of the RAG2
promoter. DNA sequences in the vicinity of this hyper-
sensitive site had B lineage and DN T cell enhancer
activity in transgenic mice (Wei et al., 2002), consistent
with the BAC transgenic studies noted above. Finally,
a third group (Monroe et al., 1999), using transfected
RAG2/ ES cells and the RAG2/ blastocyst comple-
mentation assay, reported that a genomic fragment con-
taining the RAG2 promoter region and 9 kb of 5 se-
quence is sufficient to rescue both B and T cell
development, suggesting that 9 kb of sequence up-
stream of the RAG2 promoter has adequate information
to direct RAG2 expression in both B and T lineages.
None of these studies revealed the existence of a cis-
regulatory element within sequences between 10 kb to
30 kb 5 of the RAG2 promoter. In the case of the BAC
transgene reporters in particular, the region encoding
Erag was fully dispensable for B cell-specific RAG ex-
pression (Yu et al., 1999). This is surprising given the
striking effect of Erag deletion reported in the present
study. It is possible, however, that despite their large
size, BAC transgenic reporter constructs are subject to
position effects. Furthermore, these large reporters may
still be missing sequences from within the locus that
are necessary to see the effects of Erag. It is also possi-
ble that the BAC reporter transgenes integrate into the
chromosome as tandem multicopy arrays and that this
Figure 7. E2A Binds to Erag In Vivo within Pro-B Cells and Can type of chromosomal structure obviates the requirement
Activate an Erag-Dependent Reporter Construct in Nonlymphoid for Erag activity. Our cell line studies suggest that Erag
Cells may function, at least in part, by overcoming the repres-
(A) Chromatin immunoprecipitation of E2A-associated DNA se- sive effects of chromatin structure. Tandem arrays of
quences. Crosslinked chromatin from either a control pro-B cell line transgenes might be less subject to this sort of chroma-
or a pro-B cell line expressing dual-epitope-tagged E2A protein was
tin effect than a single copy genetic locus. Finally, thefractionated using metal-affinity chromatography and anti-FLAG an-
half-life of the GFP reporter protein in developing lym-tibody and analyzed by PCR for enrichment of the mb-1 promoter,
phocytes may be such that it is an insensitive indicatorRAG1 promoter, a previously described RAG locus enhancer, or
Erag. Input indicates unfractionated chromatin. PCR assays pro- of changes in RAG locus transcript levels.
grammed with undiluted and 3-fold-diluted DNA samples are shown. While the deletion of Erag results in a partial block in
(B) Chromatin immunoprecipitation of E2A-associated DNA se- B cell development, RAG mRNA expression was not
quences from thymocytes expressing dual-epitope-tagged E2A pro-
completely abolished. It would be of interest to testtein performed as in (A). The CD4 enhancer sequence contains a
whether Erag and the previously identified DNase I hy-previously studied E2A binding site and serves as a positive control.
persensitive site enhancer element (Wei et al., 2002)(C) Transient tranfection luciferase assays. The indicated reporter
constructs were transiently transfected along with a pCMV--gal might cooperate to result in stronger B cell-specific en-
control vector and either empty pCDNA or pCDNA-E47. Eragm6 is hancement of RAG promoter activity in the stable trans-
a version of Erag with point mutations disrupting each of its six fection assay. Several sets of experiments have revealed
potential E2A binding sites. Cells were harvested after 40–48 hr and
that subset- and stage-specific expression of the CD4analyzed for -galactosidase and luciferase activity. The data, after
and CD8/ genes is achieved by combined actions ofnormalization based on-gal activity, is plotted as luciferase expres-
different cis-elements (Ellmeier et al., 1999). A similarsion relative to each promoter construct cotransfected with empty
pCDNA (black bars). The error bars indicate standard deviation of situation exists in the murine TCR locus where two
three independent experiments. enhancer elements separated by many kilobases of DNA
are both required for appropriate TCR locus transcrip-
tion (Xiong et al., 2002). Thus, it is likely that a set ofcolleagues, using modified bacterial artificial chromo-
elements is involved in generating the observed patternsome (BAC) clones of the RAG locus as transgenic re-
of transcriptional regulation of RAG gene expression inporter constructs, demonstrated that at least two distinct
developing B and T cells.regulatory elements 5 of the RAG2 promoter appear to
be required for proper expression of RAG1 and RAG2
in the B and T cell lineages (Yu et al., 1999). One such Mechanisms of Action of Erag
Since activation of transcription by Erag was very ineffi-element, which could activate reporter expression in B
cell progenitors as well as CD4CD8 double-negative cient when assayed by transient as compared to stable
transfection in pro-B cell lines, we conclude that chro-(DN) T cell precursors, was localized to a 10 kb region
immediately 5 of the RAG2 promoter. A second element mosomal structure is involved in the mechanism of Erag
function. In this context, we hypothesize that Erag maynecessary for proper RAG expression in DP thymocytes
was found to lie between 30 kb and 70 kb 5 of the serve as a “platform” to recruit general chromatin re-
Conserved RAG Locus Enhancer
115
viously described (Dillon et al., 2000). The following antibodies weremodeling factors. Our comparison of the Erag sequence
obtained from BD PharMingen (San Diego, CA): FITC-anti-IgMa/bamong a group of five mammalian species revealed sev-
(II/4), -CD4 (RM4-5); PE-anti-B220 (RA3-6B2), -IgD (11-26), -CD4eral conserved transcription factor binding sites. Of par-
(RM4-5), -CD25 (PC61), -CD8 (53-6.7); Cyc-anti-CD44 (IM7), -B220
ticular interest are binding sites for E2A, Pax5/BSAP, (RA3-6B2). Bi-anti-CD43 (S7) was purified in our laboratory. The
GATA, Ikaros, and LEF-1. Mutations in the genes encod- remaining antibodies were purchased from Caltag (San Francisco,
CA): bi-anti-CD3 (500A2), -CD4 (CT-CD4), -CD8 (CD-CD8a). PE-ing each of these factors have profound effects on early
streptavidin was obtained from Sigma. FACS analysis was per-lymphoid development (reviewed in Henderson and Ca-
formed on an Elite XL flow cytometer (Beckman Coulter) and datalame, 1998).
were analyzed with Flowjo (Tree Star, Inc.).
We found that E2A but not GATA-3 expression could For sorting of pro-/pre-B cells, BM B cells from mutant and wild-
activate either RAG promoter in an Erag-dependent type mice were enriched by negative selection using rat anti-mouse
fashion in nonlymphoid 293T cells and that mutation of IgM MicroBeads (Miltenyi Biotech), followed by positive selection
using CD19 MicroBeads. Cells were then stained with anti-B220the E2A binding sites within Erag abrogated this effect
and anti-CD43 and sorted into B220CD43 and B220CD43 frac-(Figure 7C). This, combined with ChIP data showing that
tions. DN thymocytes were isolated by staining thymocytes with bi-E2A is bound to Erag in transformed pro-B cells (Figure
anti-CD3, bi-anti-CD4, and bi-anti-CD8 followed by negative selection
7A), strongly implicates E2A in the mechanism of Erag using SA-MicroBeads. DP thymocytes were purified from mutant
function. Interestingly, we found that E2A is bound to and wild-type thymocytes stained with PE-anti-CD4 and FITC-anti-
CD8 by use of Epic Elite flow cytometer (Beckman Coulter). PurityErag in thymocytes (Figure 7B) despite the fact that RAG
of all of the sorted cells was 93%–97% as determined by re-analysis.expression is normal in Erag/ thymus. This observa-
tion suggests that Erag likely requires factors in addition
Real-Time RT-PCR Analysis of RAG mRNA Expression
to E2A for full activity or that even when active, Erag is Total RNA from sorted cells was isolated using Trizol (Invitogen),
not limiting for RAG expression in T lineage cells. Further primed with random hexamers, and reverse-transcribed with Super-
in vivo footprinting, ChIP, and mutational analyses will Script II (Invitrogen) or Omniscript (QIAGEN) according to the manu-
facturer’s protocols. Real-time PCR analysis utilized an ABI Prismbe required to define the minimal Erag sequence and
5700 Sequence Detection System (Applied Biosystems) and wasto determine which other transcription factors contrib-
carried out in accord with the manufacturer’s instructions. In mostute to the lineage-restricted activity of Erag. cases, data were represented as transcript abundance relative to
HPRT, except the experiment shown in Figure 6, in which RAG
Experimental Procedures transcripts were normalized to CD19 abundance. Real-time PCR
was carried out in duplicate or triplicate at 95C for 10 min, followed
Cell Culture and Stable Transfection Reporter Assay by 40 cycles of 95C for 15 s and 60C for 1 min. Data collected
The reporter construct shown in Figure 1B has been previously were analyzed using sequence detection software supplied with the
described (Wang et al., 2000). The 2.3 kb murine XbaI enhancer instrument and plotted using Microsoft Excel. The following primers
fragment (Fragment C in Figure 1A) was cloned in both orientations and probes were used. RAG1 sense 5-CATTCTAGCACTCTGGC
into a polylinker site upstream of either the RAG1 promoter (from CGG, RAG1 anti-sense 5-TCATCGGGTGCAGAACTGAA, RAG1
243 to 72, [Brown et al., 1997]) or RAG2 promoter (from 279 probe FAM-5-AAGGTAGCTTAGCCAACATGGCTGCCTC-3-Tamra,
to 123 [Lauring and Schlissel, 1999]). A 1 kb XbaI fragment con- RAG2 sense 5-TTAATTCCTGGCTTGGCCG, RAG2 anti-sense 5-TTC
taining the E enhancer and a 4 kb HindIII fragment containing the CTGCTTGTGGATGTGAAAT, RAG2 probe FAM-5-AGGGATAAGCA
E enhancer were used as positive controls. Conditions for growth, GCCCCTCTGGCC-3-Tamra, CD19 sense 5-AATCCACGCATTCAA
electorporation, and selection of stable transfectants of all cell lines GTCCAG, CD19 anti-sense 5-GAGCCCTCCTCGCTGTCTG, CD19
probe FAM-5-CTTCTTCCAGTCCTGTTTCATGGCTCTGAG-3-Tamra.were described previously (Lauring and Schlissel, 1999). For single
For the quantitation of HPRT, the PCR reactions were done ascell cloning, individual G418-resistant clones were generated by
previously described (Grogan et al., 2001).limiting dilution of previously generated resistant pools.
LM-PCRTargeted Deletion of Erag
Genomic DNA was isolated and LM-PCR performed as describedSee Supplemental Data at http://www.immunity.com/cgi/content/
previously (Constantinescu and Schlissel, 1997; Schlissel et al.,full/19/1/105/DC1.
1993; Stanhope-Baker et al., 1996). LM-PCR products were sepa-
rated on a 2% agarose gel, transferred to a nylon membrane (Hy-B Cell Culture
bond XL, Amersham) under alkaline conditions, and hybridized withB cell precursors from mutant and wild-type mice were grown in
32P-labeled locus-specific internal oligonucleotide probes as pre-vitro as previously described (Melamed and Nemazee, 1997). In
viously described. Approximately 800 bp of germline sequence ex-
brief, BM cells were depleted of erythrocytes using buffered NH4Cl tending from 5 of JH1 to 3 of JH2 was PCR amplified from pro-B cellsolution and filtered through sterile nylon mesh to removed bone
genomic DNA with the primers 0 and JHB3 as described previouslyfragments and debris. Cells were cultured at 2  106 cells/ml for 5
(Constantinescu and Schlissel, 1997; Schlissel, 1998). The products
days with IMDM (GIBCO) supplemented with 10% FCS (a gift from of control CD14 amplification (typically 26 cycles) were detected by
Dr. D. Namazee) and 50-100 U/ml of IL-7, derived from the culture ethidium bromide staining of 2% agarose gel. Primers for CD14
supernatant of J558L cells transfected with the murine IL-7 cDNA. amplification were previously described (Schlissel et al., 1993).
For induction of differentiation, cells were harvested, washed three
times in medium without IL-7, and cultured on a semiconfluent layer T Cell Activation
of -irradiated S17 stromal cells for 24 to 36 hr in medium without T cell stimulation was performed as previously described (Turka et
IL-7. At day 6 or day 7 of cultures, B cell precursors were harvested al., 1991). In brief, unfractionated thymocytes were freshly isolated
and then stained with FITC-anti-IgM and PE-anti-IgD. IgMIgD from Erag/ mice and wild-type littermates (3–4 weeks old). 5 
immature B cells were sorted into IgMlowIgD and IgMhighIgD cell 105 or 106 cells were incubated in duplicate with plate-bound anti-
populations. Sorted cells were washed and recultured for 48 hr on CD3 (145-2C11, a gift from Dr. J. Allison, coated 5 g/ml), or anti-
monolayers of irradiated S17 in the absence or presence of (Fab)2 CD4 (RM4-5, BD Pharmingen, coated 5 g/ml) or medium alone for
anti-mouse IgM (Jackson ImmunoResearch). the indicated times.
Flow Cytometry and Sorting Transient Transfection Assay
Single-cell suspensions from BM (two femurs), thymus, and spleen All mutations in six E2A binding sites were made using the Quick-
were prepared and stained with fluorochrome (FITC, PE, or Cy- change mutagenesis kit (Stratagene). The sequences of mutagenic
primers used for simultaneous mutagenesis were as follows:chrome)- or biotin-conjugated (bi) monoclonal antibodies as pre-
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5-GGTACCACAGCagCCTGGAAGCCTGGAGCCGGTCAG-3, of the chicken beta-globin domain serves as an insulator in human
erythroid cells and protects against position effect in Drosophila.5-GGCGATCTGCCAGTgcCAAGAGTATCAAAACAATGCTAAGC-3,
5-GGGTAAGAGGGCCAGCgcCTTGCTATATTTTTCTCTGTGG-3, Cell 74, 505–514.
5-AAAGACTCCTCAGAgcAGAAGgcTGTGGCTTTGAACAAGT Constantinescu, A., and Schlissel, M.S. (1997). Changes in locus-
AAC-3, specific V(D)J recombinase activity induced by immunoglobulin
5-CGCTCTCCTGTCAGTgcTCTGCTCCTCAGTGCTCTCTG-3 gene products during B cell development. J. Exp. Med. 185,
The E box sequences were shown in bold, with lowercase letters 609–620.
representing nucleotide substitutions. The 2.3 kb wild-type or mu-
Dillon, S.R., Mancini, M., Rosen, A., and Schlissel, M.S. (2000).tant versions of murine Erag fragment were cloned into a polylinker
Annexin V binds to viable B cells and colocalizes with a marker ofsite 5of either the RAG1 (243/72) or RAG2 promoter (279/
lipid rafts upon B cell receptor activation. J. Immunol. 164, 1322–
123) from the pR1p/R2p-Luc promoter-only constructs described
1332.previously (Lauring and Schlissel, 1999). 2 g of each luciferase
Ellmeier, W., Sawada, S., and Littman, D.R. (1999). The regulationreporter construct together with 250 ng of pCMV--gal and 1 g of
of CD4 and CD8 coreceptor gene expression during T cell develop-either empty vector (pCDNA3) or expression plasmids coding for
ment. Annu. Rev. Immunol. 17, 523–554.either E47 (pCDNA-E47) or GATA-3 (pCDNA-GATA-3) were trans-
fected into 293T cells using Polyfect (Qiagen) according to the manu- Fugmann, S.D., Lee, A.I., Shockett, P.E., Villey, I.J., and Schatz,
facturer’s instructions. Cells were harvested 40–48 hr later and as- D.G. (2000). The RAG proteins and V(D)J recombination: complexes,
sayed for both luciferase and -galactosidase activities as ends, and transposition. Annu. Rev. Immunol. 18, 495–527.
described (Lauring and Schlissel, 1999). Transfection efficiency was Fuller, K., and Storb, U. (1997). Identification and characterization
normalized using -galactosidase activity and measured relative to of the murine Rag1 promoter. Mol. Immunol. 34, 939–954.
a promoterless control luciferase construct. Each assay was per-
Grawunder, U., Leu, T.M., Schatz, D.G., Werner, A., Rolink, A.G.,formed in triplicate.
Melchers, F., and Winkler, T.H. (1995). Down-regulation of RAG1 and
RAG2 gene expression in preB cells after functional immunoglobulinChromatin Immunoprecipitation
heavy chain rearrangement. Immunity 3, 601–608.Fixed, soluble chromatin was prepared and analyzed essentially as
Greenbaum, S., and Zhuang, Y. (2002). Identification of E2A targetdescribed from a wild-type Abelson virus transformed pro-B cell
genes in B lymphocyte development by using a gene tagging-basedline and a mutant cell line expressing a FLAG and 6xhis-tagged E2A
chromatin immunoprecipitation system. Proc. Natl. Acad. Sci. USAgene or from thymocytes isolated from a FLAG and 6xhis-tagged
99, 15030–15035.E2A mutant mouse (Greenbaum and Zhuang, 2002). Crosslinked
E2A-bound DNA fragments were purified by sequential Talon metal Grogan, J.L., Mohrs, M., Harmon, B., Lacy, D.A., Sedat, J.W., and
affinity resin (Clontech) and anti-FLAG epitope immunoaffinity chro- Locksley, R.M. (2001). Early transcription and silencing of cytokine
matography. A series of 3-fold dilutions of input chromatin and genes underlie polarization of T helper cell subsets. Immunity 14,
immunoprecipitated DNA from E2AFH and E2AGFP control cell lines 205–215.
or thymocytes were PCR amplified for 38 cycles (94C 1 min; 57C Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D., and Haya-
1 min; 72C 1 min with 2 min final extension at 72C) in a 20 l kawa, K. (1991). Resolution and characterization of pro-B and pre-
PCR reaction containing 3 mM MgCl2 and Platinum Taq polymerase pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173,
(Invitrogen). Each entire PCR sample was then resolved on a 1% 1213–1225.
agarose gel and visualized by ethidium bromide staining. Oligonu-
Henderson, A., and Calame, K. (1998). Transcriptional regulationcleotide primers (IDT DNA) used in PCR for Erag detection were:
during B cell development. Annu. Rev. Immunol. 16, 163–200.ERAG1 (5- TATTCAGGAGGGAATTAAATGAC-3) and ERAG2 (5-GAC
AGAACCCGAGGGCTTAGCAT-3). Primers for the RAG1 promoter, Kurioka, H., Kishi, H., Isshiki, H., Tagoh, H., Mori, K., Kitagawa,
RAG2 enhancer (Wei et al., 2002), and mb-1 promoter were de- T., Nagata, T., Dohi, K., and Muraguchi, A. (1996). Isolation and
scribed previously (Greenbaum and Zhuang, 2002). characterization of a TATA-less promoter for the human RAG-1
gene. Mol. Immunol. 33, 1059–1066.
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